Canadian Journal of Gastroenterology and Hepatology (Jan 2014)

One Year of Hepatitis B Immunoglobulin Plus Tenofovir Therapy is Safe and Effective in Preventing Recurrent Hepatitis B Infection Post-Liver Transplantation

  • Tomohiro Tanaka,
  • Eberhard L Renner,
  • Nazia Selzner,
  • George Therapondos,
  • Leslie B Lilly

DOI
https://doi.org/10.1155/2014/839014
Journal volume & issue
Vol. 28, no. 1
pp. 41 – 44

Abstract

Read online

BACKGROUND: Hepatitis B immunoglobulin (HBIG) given in combination with a nucleos(t)ide analogue has reduced the rate of recurrent hepatitis B virus (HBV) infection following liver transplantation (LT); however, the most effective protocol remains unclear.